Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Biote Q3 EPS $0.24 Beats $0.07 Estimate, Sales $45.56M Miss $47.90M Estimate

Author: Benzinga Newsdesk | November 07, 2023 06:55pm
Biote (NASDAQ:BTMD) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.07 by 242.86 percent. This is a 113.79 percent increase over losses of $(1.74) per share from the same period last year. The company reported quarterly sales of $45.56 million which missed the analyst consensus estimate of $47.90 million by 4.89 percent. This is a 8.55 percent increase over sales of $41.97 million the same period last year.

Posted In: BTMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist